Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma
Heakal, Y., Kester, M., Savage, S.Volume:
45
Year:
2011
Language:
english
Pages:
7
DOI:
10.1345/aph.1q363
File:
PDF, 164 KB
english, 2011